BackRedhill Biopharma Overview

Redhill Biopharma Current Assets

Latest current assets for RDHL: $6.5M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$6.53M
↓ 45.19% YoYΔ $-5.38M vs prior year quarter

Peer trimmed avg / median

Loading

Redhill Biopharma Current Assets History

Loading

Redhill Biopharma vs. peers: Current Assets Comparison

Loading

Redhill Biopharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Redhill Biopharma (RDHL) FAQ

As of the most recent data (December 2025), RDHL shows a current assets of $6.5M. That compares with $12M in the prior-year period — down 45.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RDHL's current assets is now $6.5M (was $12M) — a 45.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Redhill Biopharma is outperforming or lagging.

Tracking RDHL's current assets over time shows whether Redhill Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $6.5M That compares with $12M in the prior-year period — down 45.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Redhill Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $6.5M) with ownership activity and broader fundamentals.

Redhill Biopharma's current assets is $6.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.